Jane Street Group, LLC Ptc Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $444 Billion
  • Q4 2024

A detailed history of Jane Street Group, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 165,918 shares of PTCT stock, worth $9.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
165,918
Previous 238,708 30.49%
Holding current value
$9.17 Million
Previous $8.86 Million 15.44%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$34.99 - $52.07 $2.55 Million - $3.79 Million
-72,790 Reduced 30.49%
165,918 $7.49 Million
Q3 2024

Nov 14, 2024
SELL
$30.39 - $37.66 $3.13 Million - $3.88 Million
-103,122 Reduced 30.17%
238,708 $8.86 Million
Q2 2024

Aug 14, 2024
BUY
$24.69 - $40.12 $6.1 Million - $9.92 Million
247,141 Added 261.0%
341,830 $10.5 Million
Q1 2024

May 15, 2024
SELL
$24.15 - $31.95 $17.5 Million - $23.1 Million
-723,169 Reduced 88.42%
94,689 $2.75 Million
Q4 2023

Feb 14, 2024
BUY
$18.07 - $29.37 $11.5 Million - $18.7 Million
638,134 Added 355.06%
817,858 $22.5 Million
Q3 2023

Nov 14, 2023
BUY
$22.41 - $41.99 $878,965 - $1.65 Million
39,222 Added 27.92%
179,724 $4.03 Million
Q2 2023

Aug 14, 2023
BUY
$40.4 - $59.1 $4.38 Million - $6.4 Million
108,374 Added 337.32%
140,502 $5.71 Million
Q1 2023

May 15, 2023
BUY
$38.16 - $48.86 $939,880 - $1.2 Million
24,630 Added 328.49%
32,128 $1.56 Million
Q4 2022

Feb 14, 2023
SELL
$33.53 - $54.79 $781,986 - $1.28 Million
-23,322 Reduced 75.67%
7,498 $286,000
Q3 2022

Nov 14, 2022
SELL
$41.85 - $53.85 $506,008 - $651,100
-12,091 Reduced 28.18%
30,820 $1.55 Million
Q2 2022

Aug 16, 2022
BUY
$25.6 - $45.23 $781,670 - $1.38 Million
30,534 Added 246.7%
42,911 $1.72 Million
Q1 2022

May 17, 2022
BUY
$33.33 - $44.6 $102,889 - $137,680
3,087 Added 33.23%
12,377 $462,000
Q4 2021

Feb 15, 2022
SELL
$35.36 - $41.86 $80,832 - $95,691
-2,286 Reduced 19.75%
9,290 $369,000
Q3 2021

Nov 16, 2021
SELL
$37.01 - $44.74 $322,579 - $389,953
-8,716 Reduced 42.95%
11,576 $431,000
Q1 2021

May 18, 2021
SELL
$46.8 - $68.92 $151,819 - $223,576
-3,244 Reduced 13.78%
20,292 $961,000
Q4 2020

Feb 17, 2021
SELL
$47.96 - $67.64 $473,413 - $667,674
-9,871 Reduced 29.55%
23,536 $1.44 Million
Q3 2020

Nov 17, 2020
SELL
$45.41 - $57.07 $2.39 Million - $3 Million
-52,574 Reduced 61.15%
33,407 $1.56 Million
Q2 2020

Aug 17, 2020
BUY
$42.56 - $54.98 $3.39 Million - $4.38 Million
79,581 Added 1243.45%
85,981 $4.36 Million
Q1 2020

May 15, 2020
SELL
$32.37 - $59.36 $108,633 - $199,212
-3,356 Reduced 34.4%
6,400 $285,000
Q4 2019

Feb 14, 2020
SELL
$32.22 - $50.07 $115,830 - $180,001
-3,595 Reduced 26.93%
9,756 $469,000
Q3 2019

Nov 14, 2019
BUY
$33.82 - $48.17 $285,880 - $407,181
8,453 Added 172.58%
13,351 $452,000
Q2 2019

Aug 15, 2019
SELL
$35.42 - $45.0 $135,339 - $171,945
-3,821 Reduced 43.82%
4,898 $220,000
Q1 2019

May 16, 2019
BUY
$28.09 - $39.49 $244,916 - $344,313
8,719 New
8,719 $328,000
Q4 2018

Feb 15, 2019
SELL
$29.83 - $46.51 $456,577 - $711,882
-15,306 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$33.9 - $47.77 $518,873 - $731,167
15,306 New
15,306 $719,000
Q2 2018

Aug 15, 2018
SELL
$25.7 - $47.88 $560,003 - $1.04 Million
-21,790 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$17.46 - $32.59 $380,453 - $710,136
21,790 New
21,790 $590,000
Q4 2017

Feb 15, 2018
SELL
$15.14 - $20.89 $1.19 Million - $1.65 Million
-78,768 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$16.81 - $21.61 $1.32 Million - $1.7 Million
78,768
78,768 $1.58 Million

Others Institutions Holding PTCT

# of Institutions
258
Shares Held
77.4M
Call Options Held
179K
Put Options Held
536K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.95B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email